Wound Stasis System (WSS) Program | Apply Online

Opportunity Summary:

The Wound Stasis System (WSS) Program (DARPA BAA 09-29) is a Defense Advanced Research Projects Agency effort, managed through DARPA's Defense Sciences Office, aimed at dramatically improving battlefield bleeding control through a new combination of advanced materials and a practical delivery device. The core objective is to develop a materials-based hemostatic agent (or multiple agents working together) and an accompanying delivery system that can rapidly target damaged tissue, stop bleeding, and stabilize wounds in a way that is effective across a wide range of injury types. The program is framed around military operational needs, where uncontrolled hemorrhage remains a leading cause of preventable death and where treatment often must be performed quickly, under stress, and in difficult environments.

A central emphasis of the opportunity is broad applicability: the proposed solution must be capable of treating both compressible wounds (injuries where direct pressure can be applied, such as many extremity wounds) and non-compressible wounds (injuries where pressure is difficult or impossible to apply effectively, such as certain junctional areas or internal bleeding scenarios). DARPA also highlights that the system should work regardless of wound geometry and location, signaling interest in technologies that can conform to irregular wound shapes, penetrate or reach challenging anatomical sites, and remain effective even when traditional dressings, gauze packing, or pressure-based methods are inadequate. In practical terms, this suggests a need for agents that can localize to the bleeding source, adhere or seal effectively in wet and dynamic environments, and function reliably despite variability in wound presentation.

The expected end state is not just a laboratory proof-of-concept, but a field-relevant capability: successful completion should produce a hand-held delivery system designed for real-world use by military personnel. That implies the program is interested in solutions that can be deployed quickly and intuitively, with minimal setup, and that can deliver the hemostatic material in a controlled manner. While the synopsis does not list detailed performance thresholds, the language about "improved wound outcome" indicates that DARPA is looking beyond immediate bleeding stoppage toward secondary benefits such as reduced tissue damage, better preservation of viable tissue, improved healing trajectories, and potentially fewer complications after evacuation and definitive care.

Administratively, this is a discretionary science and technology research and development funding opportunity, listed under CFDA 12.910 (Research and Technology Development). DARPA indicates multiple potential award instruments may be used, including cooperative agreements, grants, other transactions, and procurement contracts, giving the agency flexibility in how it structures and manages selected efforts. There is no cost sharing or matching requirement, which can make participation easier for academic groups, small businesses, and other research performers that may not have the ability or desire to commit non-federal funds.

Eligibility is listed as unrestricted, meaning it is open to any type of entity, subject to any additional clarifications contained in the full announcement text. The opportunity was posted on March 17, 2009, with an original and current closing date of March 16, 2010, and an archive date of April 16, 2010. Parties needing access to the full announcement were directed to contact the BAA Coordinator. The full technical and submission requirements are contained in the attachment referenced as "DARPA BAA 09-29," which would typically include the detailed scope, desired technical approaches, metrics, schedule and phases (if any), deliverables, proposal formatting instructions, and evaluation criteria.

Browse more opportunities from the same agency: DARPA Defense Sciences Office

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: Dynamic Prevention of Biofouling (DyPOB)

Previous opportunity: Technological Innovation and Cooperation for Foreign Information Access Program CFDA 84.337A

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for DARPA BAA 09 29

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (DARPA BAA 09 29) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "DARPA BAA 09 29", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.